Seeing Blind Oct22

Seeing Blind

Breakthrough innovation enables the legally blind to see MaRS client’s device unique among low vision aids TORONTO, Oct. 22, 2013 — MaRS client and Investment Accelerator Fund portfolio company eSight Corporation is pleased to announce the launch of eSight eyewear, the first...

Cell Collaboration Oct19

Cell Collaboration

Scotland demonstrates its collaborative approach to cell therapy development Scottish Development International and leading industry players, Sistemic and Roslin Cells, are committed to linking cell therapy clinical trials to the most up-to-date technologies to drive wider adoption of the...

Biomarker Panels Oct18

Biomarker Panels

Genalyte Expands Into Cancer Profiling With $1 Million NCI Grant To Develop Cancer Biomarker Panel; Establishes Collaborations With Three Cancer Research Centers — Collaboration will Assemble and Validate a Tumor Antigen-Associated (TAA) Autoantibody Biomarker Panel for Tumor...

Immunosequencing Oct17

Immunosequencing

Adaptive Biotechnologies Receives Critical Intellectual Property for Next Generation Immunosequencing Field The allowed claims cover compositions and methods that allow for Next Generation Sequencing (NGS) to be applied to cells of the adaptive immune system SEATTLE, Oct. 17, 2013 —...

Speed Shift Oct16

Speed Shift

BME Introduces The Speed™ Shift™ Continuous Active Compression System Designed For Sliding Calcaneal Osteotomies SAN ANTONIO, Oct. 16, 2013 — BME, Inc. (BioMedical Enterprises, Inc., www.bme-tx.com) is the privately held U.S. leader in shape memory technology for small bone...

Valeo II Oct15

Valeo II

Amedica Launches Valeo II Anterior Lumbar Interbody Spinal Fusion Device Redesigned Device Provides Surgeons with Ease of Use While Ensuring Quality Patient Care SALT LAKE CITY, Oct. 15, 2013 — Amedica Corporation, a biomaterial company, today announced the launch of its new Silicon...

Androforte Oct12

Androforte

Treat Low T with Androforte from TestoMeds TestoMeds is now offering discounted Androforte, the leading treatment for Low Testosterone BET SHEMESH, Israel — Childhood is an important time in any person’s life, but it can’t last forever. Every culture in the world delineates...

Diabetic Insights Oct11

Diabetic Insights

ClinMet Metabolomics Platform Offers Unique Insights into Diabetic Kidney Disease Newly Published Research by ClinMet Founder and UC San Diego Team Demonstrates Value of Urine-based Metabolomics to Translational Medicine SAN DIEGO, Oct.11, 2013 — ClinMet today announced that researchers...

Vaginal Ring Oct10

Vaginal Ring

Particle Sciences Completes Manufacture of New Vaginal Ring for HIV Prevention BETHLEHEM, Pa., Oct. 10, 2013 — Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO) , has completed the clinical trial manufacturing of vaginal rings with a unique...

MAJESTIC trial Oct09

MAJESTIC trial

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System MAJESTIC Trial To Study Self-Expanding DES System Designed To Treat Superficial Femoral Artery (SFA) Lesions NATICK, Mass., Oct. 9, 2013 — Launching a key clinical trial expected to serve...

Immune Repertoire Oct08

Immune Repertoire

Adaptive Biotechnologies Study Reveals Homogeneous Immune Repertoire in Solid Tumors Study co-led by Fred Hutchinson Cancer Research Center dispels notion of immune system as spatially heterogeneous as cancer genome SEATTLE, Oct. 8, 2013 — Adaptive Biotechnologies Corporation, a...

Bowel Biosimilars Oct05

Bowel Biosimilars

Gastroenterologists Unlikely To Use Celltrion/Hospira’s Infliximab Biosimilar Due To Lack Of Clinical Data In Inflammatory Bowel Disease Rheumatologists Expect More Extensive Clinical Trials for Biosimilars than Gastroenterologists, According to a New Report from BioTrends Research...

Unreliable Kits Oct04

Unreliable Kits

Unreliable Commercial Lab Kits May Be Hindering the Fight Against Cancer WASHINGTON, Oct. 4, 2013 — Over the past 30 years, researchers have developed surprisingly few new tests for diagnosing cancer in spite of impressive advances in biomedical technology. A study appearing online...

Cira Platform

Pacific Biomarkers Adopts Aushon BioSystems’ Cira Platform for Biomarker Testing Aushon BioSystems and Pacific Biomarkers Announce The Adoption by Pacific Biomarkers of Aushon’s Cira™ Platform for Biomarker Testing BILLERICA, Mass, Oct. 3, 2013 — Aushon Biosystems, a...

Lupus Treatment Oct02

Lupus Treatment

New ALR-LRI Collaboration to Accelerate New Treatments for Lupus NEW YORK, Oct. 2, 2013 — Today, the Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) announced a trailblazing cooperative project to speed up the identification and availability of new treatments...

Automated IHC Oct01

Automated IHC

Ventana launches first fully automated IHC test to detect BRAF V600E mutation in a variety of cancers Exclusive license agreement paves the way for industry’s first BRAF V600E IHC test TUCSON, Ariz., Oct 1, 2013 — Ventana Medical Systems, Inc. (Ventana), a member of the Roche...

mariPOC Diagnostics Sep28

mariPOC Diagnostics

mariPOC® Rapid Respiratory Tract Diagnostics Sales Network is now 16 Countries Strong in Europe TURKU, Finland — ArcDia Ltd (http://www.arcdia.com). ArcDia International Ltd today announced the expansion of its distributor and service network to cover 18 countries...

Transgenic Mouse Sep27

Transgenic Mouse

Trianni Announces Launch of Its Optimized Human Antibody Transgenic Mouse EMERYVILLE, Calif. — Trianni, Inc., a Californian biotechnology company, announced today the launch of its Trianni Mouse, a monoclonal antibody discovery platform optimized for isolation of best-in-class...

Protein Degradation Sep26

Protein Degradation

Arvinas Secures $18.25 Million to Advance Clinical Programs Focused on Protein Degradation Protein Degradation Platform Represents a New Class of Drugs NEW HAVEN, Conn., Sept. 26, 2013 — Arvinas Inc., a biotechnology company creating a new class of drugs based on protein degradation,...

STEMSOFT CORD Sep25

STEMSOFT CORD

STEMSOFT Announces Release of New Cord Banking Software Solution VANCOUVER, British Columbia, Sept. 25, 2013 — STEMSOFT™ Software Inc. (“STEMSOFT”) is pleased to announce the release of a new cord banking software solution, STEMSOFT CORD.  This new system is like no...

Fasciotomy Savings Sep24

Fasciotomy Savings

Clinical Study Shows DermaClose® RC Achieved Delayed Primary Closure in 93% of Fasciotomy Wounds with Cost Savings of Up To $7,858 Breaking News for Surgeons CHANHASSEN, Minn., Sept. 24, 2013 — Wound Care Technologies, Inc., a Minnesota based emerging medical technology company...

Monaco 5.0 Sep21

Monaco 5.0

Elekta Announces Monaco 5.0 — Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System New workflow and system architecture designed to improve processing speed, enhance planning productivity ATLANTA, Sept. 21, 2013 – Elekta today announced Monaco® 5.0,...

Light Lens Sep20

Light Lens

Hoopes Vision Surgeon First in Utah to Implant New Light Adjustable Artificial Lens SALT LAKE CITY, Sept. 20, 2013 — On September 4th Dr. Phillip C. Hoopes, Jr., a surgeon at Hoopes Vision, successfully placed a light adjustable intraocular lens implant in a cataract patient as part...

MSDC-0160 Sep19

MSDC-0160

Investigational Diabetes Drug May Also Have Future As Treatment for Parkinson’s Disease New data suggests novel insulin sensitizer may prevent damage and death of nerve cells in the brain that control movement, balance, and walking KALAMAZOO, Mich., Sept. 19, 2013 — Metabolic...

KB001 Sep18

KB001

KaloBios’ KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology Human Safety and PK/PD Data from Phase 1 Study of KB001 Supports Ongoing Phase 2 Clinical Trial of KB001-A in Cystic Fibrosis SOUTH SAN FRANCISCO, Calif., Sept. 18, 2013 — KaloBios Pharmaceuticals,...

Page 1 of 1112345...10...Last »